A vaccine designed to help the body hunt down and destroy lung cancer cells has officially entered human trials, marking a major milestone in the fight against one of the deadliest diseases in the world. Researchers across seven countries have begun testing the treatment in patients, with hopes that it could dramatically improve survival rates and …
Scientists at the University of Oxford and pharmaceutical company GSK have collaborated to develop a revolutionary cancer vaccine. The vaccine aims to prevent cancer up to 20 years before it develops. This collaborative effort targets cells at the pre-cancerous stage when cancer is typically undetectable. Professor Sarah Blagden, director of the partnership, explains that cancer …
Cancer vaccines have always come with a frustrating catch. Unlike flu shots that work for millions of people, most cancer vaccines need to be custom-made for each patient. Doctors must extract tumor samples, analyze them, and build a vaccine tailored to that specific person’s cancer. By the time all that happens, months have passed, and …
The syringe contained no poison to kill cancer cells, no radioactive particles to burn through tissue, no harsh chemicals to ravage a patient’s body. Instead, it held something far more revolutionary: a set of molecular instructions that would transform a 67-year-old scientist’s immune system into a personalized cancer-hunting army. Janusz Racz didn’t know it as …